Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 329

1.

High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.

Shi Y, Wang C, Huang F, Chen Z, Sun Z, Wang J, Tang B, Ashizawa T, Klockgether T, Jiang H.

Cerebellum. 2015 Apr 14. [Epub ahead of print]

PMID:
25869927
2.

Dynamic changes of nuclear RNA foci in proliferating DM1 cells.

Xia G, Ashizawa T.

Histochem Cell Biol. 2015 Feb 26. [Epub ahead of print]

PMID:
25715678
3.

Vascular risk factors and clinical progression in spinocerebellar ataxias.

Lo RY, Figueroa KP, Pulst SM, Lin CY, Perlman S, Wilmot G, Gomez CM, Schmahmann J, Paulson H, Shakkottai VG, Ying SH, Zesiewicz T, Bushara K, Geschwind M, Xia G, Subramony SH, Ashizawa T, Kuo SH.

Tremor Other Hyperkinet Mov (N Y). 2015 Feb 2;5:287. doi: 10.7916/D89885S0. eCollection 2015.

4.

Genome Modification Leads to Phenotype Reversal in Human Myotonic Dystrophy type 1 iPS-cell Derived Neural Stem Cells.

Xia G, Gao Y, Jin S, Subramony S, Terada N, Ranum LP, Swanson MS, Ashizawa T.

Stem Cells. 2015 Feb 20. doi: 10.1002/stem.1970. [Epub ahead of print]

PMID:
25702800
5.

Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients.

Long Z, Chen Z, Wang C, Huang F, Peng H, Hou X, Ding D, Ye W, Wang J, Pan Q, Li J, Xia K, Tang B, Ashizawa T, Jiang H.

PLoS One. 2015 Feb 17;10(2):e0117488. doi: 10.1371/journal.pone.0117488. eCollection 2015.

6.

The role of the mammalian DNA end-processing enzyme polynucleotide kinase 3'-phosphatase in spinocerebellar ataxia type 3 pathogenesis.

Chatterjee A, Saha S, Chakraborty A, Silva-Fernandes A, Mandal SM, Neves-Carvalho A, Liu Y, Pandita RK, Hegde ML, Hegde PM, Boldogh I, Ashizawa T, Koeppen AH, Pandita TK, Maciel P, Sarkar PS, Hazra TK.

PLoS Genet. 2015 Jan 29;11(1):e1004749. doi: 10.1371/journal.pgen.1004749. eCollection 2015 Jan.

7.

Bolivian kindred with combined spinocerebellar ataxia types 2 and 10.

Baizabal-Carvallo JF, Xia G, Botros P, Laguna J, Ashizawa T, Jankovic J.

Acta Neurol Scand. 2015 Jan 28. doi: 10.1111/ane.12371. [Epub ahead of print]

PMID:
25630585
8.

Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.

Gao R, Liu Y, Silva-Fernandes A, Fang X, Paulucci-Holthauzen A, Chatterjee A, Zhang HL, Matsuura T, Choudhary S, Ashizawa T, Koeppen AH, Maciel P, Hazra TK, Sarkar PS.

PLoS Genet. 2015 Jan 15;11(1):e1004834. doi: 10.1371/journal.pgen.1004834. eCollection 2015 Jan.

9.

Immunologically augmented skin flap as a novel dendritic cell vaccine against head and neck cancer in a rat model.

Inoue K, Saegusa N, Omiya M, Ashizawa T, Miyata H, Komiyama M, Iizuka A, Kume A, Sugino T, Yamaguchi K, Kiyohara Y, Nakagawa M, Akiyama Y.

Cancer Sci. 2015 Feb;106(2):143-50. doi: 10.1111/cas.12586. Epub 2015 Feb 4.

PMID:
25492592
10.

Coenzyme Q10 and spinocerebellar ataxias.

Lo RY, Figueroa KP, Pulst SM, Lin CY, Perlman S, Wilmot G, Gomez C, Schmahmann J, Paulson H, Shakkottai VG, Ying S, Zesiewicz T, Bushara K, Geschwind M, Xia G, Subramony SH, Ashizawa T, Kuo SH.

Mov Disord. 2015 Feb;30(2):214-20. doi: 10.1002/mds.26088. Epub 2014 Dec 1.

PMID:
25449974
11.

Ataxia.

Akbar U, Ashizawa T.

Neurol Clin. 2015 Feb;33(1):225-48. doi: 10.1016/j.ncl.2014.09.004.

PMID:
25432731
12.

Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study.

Moscovich M, Okun MS, Favilla C, Figueroa KP, Pulst SM, Perlman S, Wilmot G, Gomez C, Schmahmann J, Paulson H, Shakkottai V, Ying S, Zesiewicz T, Kuo SH, Mazzoni P, Bushara K, Xia G, Ashizawa T, Subramony SH.

J Neuroophthalmol. 2015 Mar;35(1):16-21. doi: 10.1097/WNO.0000000000000167.

PMID:
25259863
13.

Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues.

Oyama G, Thompson A, Foote KD, Limotai N, Abd-El-Barr M, Maling N, Malaty IA, Rodriguez RL, Subramony SH, Ashizawa T, Okun MS.

Tremor Other Hyperkinet Mov (N Y). 2014 Jul 9;4:228. doi: 10.7916/D8542KQ5. eCollection 2014.

14.

Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes.

Tezenas du Montcel S, Durr A, Bauer P, Figueroa KP, Ichikawa Y, Brussino A, Forlani S, Rakowicz M, Schöls L, Mariotti C, van de Warrenburg BP, Orsi L, Giunti P, Filla A, Szymanski S, Klockgether T, Berciano J, Pandolfo M, Boesch S, Melegh B, Timmann D, Mandich P, Camuzat A; Clinical Research Consortium for Spinocerebellar Ataxia (CRC-SCA); EUROSCA network, Goto J, Ashizawa T, Cazeneuve C, Tsuji S, Pulst SM, Brusco A, Riess O, Brice A, Stevanin G.

Brain. 2014 Sep;137(Pt 9):2444-55. doi: 10.1093/brain/awu174. Epub 2014 Jun 26.

PMID:
24972706
15.

Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease.

Leonardi L, Marcotulli C, McFarland KN, Tessa A, DiFabio R, Santorelli FM, Pierelli F, Ashizawa T, Casali C.

J Neurol. 2014 Sep;261(9):1691-4. doi: 10.1007/s00415-014-7394-8. Epub 2014 Jun 17.

PMID:
24935856
16.

Quantitative trait locus analysis of resistance to panicle blast in the rice cultivar Miyazakimochi.

Ishihara T, Hayano-Saito Y, Oide S, Ebana K, La NT, Hayashi K, Ashizawa T, Suzuki F, Koizumi S.

Rice (N Y). 2014 Apr 10;7(1):2. doi: 10.1186/s12284-014-0002-9. eCollection 2014.

17.

YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line.

Akiyama Y, Ashizawa T, Komiyama M, Miyata H, Oshita C, Omiya M, Iizuka A, Kume A, Sugino T, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K.

Oncol Rep. 2014 Jul;32(1):159-66. doi: 10.3892/or.2014.3195. Epub 2014 May 16.

PMID:
24842123
18.

Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.

Ashizawa T, Akiyama Y, Miyata H, Iizuka A, Komiyama M, Kume A, Omiya M, Sugino T, Asai A, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K.

Int J Oncol. 2014 Jul;45(1):411-8. doi: 10.3892/ijo.2014.2439. Epub 2014 May 12.

PMID:
24820265
19.

The identification of affinity peptide ligands specific to the variable region of human antibodies.

Akiyama Y, Miyata H, Komiyama M, Nogami M, Ozawa K, Oshita C, Kume A, Ashizawa T, Sakura N, Mochizuki T, Yamaguchi K.

Biomed Res. 2014;35(2):105-16.

20.

Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.

Akiyama Y, Komiyama M, Miyata H, Yagoto M, Ashizawa T, Iizuka A, Oshita C, Kume A, Nogami M, Ito I, Watanabe R, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Yamaguchi K.

Oncol Rep. 2014 Apr;31(4):1683-90. doi: 10.3892/or.2014.3049. Epub 2014 Feb 24.

PMID:
24573400
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk